Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Xeris Biopharma Holdings (XERS) Return on Assets: 2021-2025

Historic Return on Assets for Xeris Biopharma Holdings (XERS) over the last 4 years, with Sep 2025 value amounting to -0.04%.

  • Xeris Biopharma Holdings' Return on Assets rose 15.00% to -0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.04%, marking a year-over-year increase of 15.00%. This contributed to the annual value of -0.17% for FY2024, which is 2.00% up from last year.
  • Xeris Biopharma Holdings' Return on Assets amounted to -0.04% in Q3 2025, which was up 54.92% from -0.10% recorded in Q2 2025.
  • In the past 5 years, Xeris Biopharma Holdings' Return on Assets ranged from a high of -0.04% in Q3 2025 and a low of -0.56% during Q4 2021.
  • Its 3-year average for Return on Assets is -0.17%, with a median of -0.19% in 2023.
  • Its Return on Assets has fluctuated over the past 5 years, first rose by 27bps in 2022, then fell by 1bps in 2024.
  • Quarterly analysis of 5 years shows Xeris Biopharma Holdings' Return on Assets stood at -0.56% in 2021, then grew by 27bps to -0.29% in 2022, then climbed by 10bps to -0.19% in 2023, then climbed by 2bps to -0.17% in 2024, then increased by 15bps to -0.04% in 2025.
  • Its Return on Assets stands at -0.04% for Q3 2025, versus -0.10% for Q2 2025 and -0.14% for Q1 2025.